Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Medicina Clinica|June 28, 2007
[Multiple myeloma]Ramón García-Sanz, María Victoria Mateos, Jesús Fernando San Miguel
The Hematology Journal : the Official Journal of the European Haematology Association|April 18, 2002
The combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is feasible and can be an option for relapsed/refractory multiple myelomaRamón García-Sanz, Maria Isabel González-Fraile, Magdalena Sierra, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|May 29, 2004
Impact of immunophenotype on prognosis of patients with myelodysplastic syndromes. Its value in patients without karyotypic abnormalitiesJose Luis Arroyo, Ma Eugenia Fernández, Jesús Maria Hernández, et al.
Leukemia Research|September 24, 2004
Analysis of hematopoietic progenitor cells in patients with myelodysplastic syndromes according to their cytogenetic abnormalitiesNatalia López-Holgado, Jose Luis Arroyo, Carmen Pata, et al.
Haematologica|March 8, 2005
Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donorsNatalia López-Holgado, Carmen Pata, Eva Villarón, et al.
Cancer|January 28, 2003
Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemiaAna Rasillo, María Dolores Tabernero, María Luz Sánchez, et al.
Haematologica|October 18, 2006
The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myelomaMaría Eugenia Sarasquete, Ramón García-Sanz, Adriana Armellini, et al.
Hematological Oncology|September 9, 2016
Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism arrayRamón García-Sanz, Luis Antonio Corchete, Miguel Alcoceba, et al.
Haematologica|February 12, 2002
Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trialJosep-Maria Ribera, Juan-José Ortega, Albert Oriol, et al.
The Lancet. Oncology|August 27, 2010
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trialMaría-Victoria Mateos, Albert Oriol, Joaquín Martínez-López, et al.
Pageof 1